Eli Lilly’s (NYSE:LLY) blockbuster GLP-1 medication, tirzepatide, is no longer in shortage in the U.S., the U.S. Food and ...

Shares in Hims & Hers Health fell after the U.S. Food and Drug Administration said Eli Lilly's obesity and diabetes drugs are no longer in shortage. Shares were down 7% in premarket trading to $17.64.

The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list ...

This article like a handy guide can help you choose the right product for you that your physician can integrate into your ...

Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are no longer in shortage, the U.S. Food and Drug ...

The best diets are healthy eating patterns that emphasize whole, nutrient-rich plant foods and minimize heavily processed ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

A report from online drug marketplace Universal Drugstore found that pizza was the most popular junk food in America. However ...

These are the most unhealthy fast-food hamburgers in the U.S. ranked, according to a study. Nutritionists explain the ...

Fast food may not traditionally be associated with healthy eating, but everything in moderation—right? Still, not all ...

Powdered drink mix: If you have a lot of water stocked up, you might crave a sugar rush after a while. Sports drinks and ...

From hip coffee joints to supermarket shelves, oat milk has found its place in the plant-based milk trend over the last few ...